The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
The Nonmedical Use of Ketamlne, Part Two: A Review of Problent Use and Dependence
Abstract
This is the second part of a review of the nonmedical use of ketamine. Part one discussed the history of ketamine, the sought-after effects for which it is taken in a nonmedical context, how these are produced, common adverse effects, the ketamine schizophrenia model and the neurotoxicity issue. Part two reviews what is currently known about problem use of ketamine, ketamine dependence, treatment options and harm minimization issues. Some ketamine users become dependent on the drug in a manner resembling cocaine dependence, with craving and a high tolerance but no evidence of a physiological withdrawal syndrome. The likely mechanisms of this dependence are discussed in terms of what is known about the neurochemistry of ketamine, its psychological effects, and published case histories in both the formal and informal literature. The conclusions are that ketamine dependence is linked with effects that this complex drug has in common with not only cocaine and amphetamine but also with opiates, alcohol and cannabis, as well as the psychological attractions of its distinctive psychedelic properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Episodes of long duration of withdrawal symptoms (i.e., depression, anxiety, mania, tinnitus, nausea, unexplained fear, and dizziness) were described after SNRIs discontinuation, suggesting the occurrence of persistent post-withdrawal disorders [120-123].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [122]
In the citing paper
“To be noted that 3 out of the 4 studies reporting SNRI persistent post-withdrawal disorders were on venlafaxine [120-122] and 1 was on duloxetine [123].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [122]
Citations
Cites
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., Porter, R., Hartung, T., Kolczewski, S., Büttelmann, B., et al. (1909) · JAMA · doi:10.1001/jama.1909.02550020033007 · Cited by 7,889
The varieties of religious experience: A study in human nature.
James, W. (1902) · doi:10.1037/10004-000 · Cited by 5,204
(1991) · Medical Entomology and Zoology · Cited by 4,438
The American Journal of Psychiatry
(2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp · Cited by 2,616
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Psychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857
Ketamine Psychedelic Therapy (KPT): A Review of the Results of Ten Years of Research
Krupitsky, E. M., & Grinenko, A. Y. (1997) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1997.10400185 · Cited by 246
A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences
Jansen, K. L. R. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10400244 · Cited by 229
Self-citationCirculatory Responses to Ketamine Anesthesia
Tweed, W. A., Minuck, M., & Mymin, D. (1972) · Anesthesiology · doi:10.1097/00000542-197212000-00008 · Cited by 210
Herman, B. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00140-9 · Cited by 196
Research works printed but not linked: 10
- Grof S., 1988, The Adventure of Self-Discovery—Dimensions of Consciousness and New Perspectives in Psychotherapy and Inner Exploration.
- Hall C. H., 1992, The Independent, 5
- 10.1023/A:1025055109480 · DOI
- McCarthy D. A., 1976, Anaesthesiology, 399, 160
- Mills H., 1996, The Observer, 10
- Moore M., 1978, Journeys into the Bright World.
- Siegel R. K., 1978, Phencyclidine Abuse: An Appraisal.
- Sputz R., 1989, High Times, 64
- Turner D. M., 1994, The Essential Guide to Psychedelics.
- 1992, The ICD-10 Classification of Mental and Behavioural Disorders.
Cited by
Sorted by citations
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
Hijazi, Y., & Boulieu, R. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.7.853 · Cited by 287
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Ketamine abuse potential and use disorder
Liu, Y., Lin, D., Wu, B., & Zhou, W. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.05.016 · Cited by 256
Kalsi, S. S., Wood, D. M., & Dargan, P. I. (2011) · Emerging Health Threats Journal · doi:10.3402/ehtj.v4i0.7107 · Cited by 235
Metadata
- Authors
- Jansen, K. L. R., & Darracot-Cankovic, R.
- Affiliations
- St Thomas' Hospital (GB)
- Venue
- Journal of Psychoactive Drugs
- Publisher
- Informa UK Limited
- Published
- 2001-06
- Volume
- 33
- Issue
- 2
- Pages
- 151-158
- ISSN
- 0279-1072 (ISSN-L)
- 2159-9777
- OpenAlex
- W2148291000
- Cited by
- 137
- References
- 51
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 5 · 2022: 9 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 6 · 2017: 6 · 2016: 11 · 2015: 6 · 2014: 10 · 2013: 1 · 2012: 2
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychoactive Drugs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Keywords
- ketamine, ketamine dependence, problematic substance use, craving, tolerance (pharmacology and immunology), withdrawal, harm reduction, psychedelic effects
- MeSH terms
- Anesthetics, Dissociative, Animals, Drug Tolerance, Humans, Ketamine, Behavior, Addictive, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
